Correvio Pharma (CORV) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CORV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProtect Pharmaceutical Corp.wsj.com - April 19 at 9:33 AMStella Pharma Corp Ordinary Shares 4888morningstar.com - April 16 at 9:49 AMNatco Pharma gets USFDA warning letter for Kothur plantmsn.com - April 9 at 7:40 PMHold Rating Maintained for Corvus Pharmaceuticals Amid Clinical Delays and Financing Concernsmarkets.businessinsider.com - March 29 at 10:57 AMCorvus: Q4 Earnings Snapshotwashingtonpost.com - March 19 at 6:50 PM'This is a sleeping giant:' UC seals licensing deal with TRPV Pharmaceuticals for new heart failure drugbizjournals.com - March 15 at 4:10 PMCorbus Pharmaceuticals Stock Climbs on Narrower-Than-Expected 4Q Lossmarketwatch.com - March 13 at 11:07 PMGarware Fulflex India acquires Avcor Health Care Products to strengthen its medical product portfoliomsn.com - March 1 at 6:30 AMChong Kun Dang Pharmaceutical Corp.wsj.com - February 17 at 7:53 PMSilver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As Presidentfinance.yahoo.com - February 12 at 5:54 PMChong Kun Dang Pharmaceutical Corpmorningstar.com - January 14 at 12:41 AMCorvus Pharmaceuticals: Ahead Of The Clinical-Stage Curveseekingalpha.com - December 12 at 1:12 PMAbbVie is acquiring two local biotechs — but won't detail its plans for thembizjournals.com - December 7 at 2:45 PMAbbVie – Cerevel M&A deal lifts Reviva, Karunamsn.com - December 7 at 9:44 AMScout Clinical secures preferred supplier status with Top 5 Pharma Leaderbenzinga.com - November 30 at 6:38 PMCorvus Pharmaceuticals (CRVS) Price Target Increased by 10.92% to 8.03msn.com - November 27 at 10:17 AMAbbVie suing Sandoz, four others to block generic Rinvoq: reportmsn.com - November 22 at 6:32 PMVietnam Pharmaceutical Corp (DVN)investing.com - November 16 at 10:42 PMNymox Pharmaceutical Corp NYMXFmorningstar.com - November 16 at 10:42 PMNutra Pharma Corp NPHCmorningstar.com - November 14 at 6:24 PMWHO Approves First African-Manufactured Malaria Drugmsn.com - November 12 at 10:55 PMHPGC Renmintongtai Pharmaceutical Corp Class A 600829morningstar.com - November 6 at 8:33 AMAnalyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stockmarkets.businessinsider.com - October 30 at 2:10 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)markets.businessinsider.com - September 29 at 7:37 AMRAMM Pharma Corp. Announces Corporate Updatefinance.yahoo.com - September 15 at 7:29 PMJW Pharmaceutical Corp.wsj.com - August 31 at 9:54 PMNervGen Pharma Corp.: NervGen Pharma to Present on its Drug Candidate NVG-291 and Spinal Cord Injury at Investor Conferencefinanznachrichten.de - August 25 at 11:13 PMNGENF NervGen Pharma Corp.seekingalpha.com - August 22 at 5:29 PMCervoMed shares soar following merger, reverse stock splitmsn.com - August 17 at 3:27 PMInnoCan Pharma Corp (INNO)investing.com - August 2 at 4:11 AMJW Pharmaceutical Corp (001065)investing.com - July 17 at 5:51 PMAurobindo Pharma Healthcare Receives USFDA Approval For Sevelamer Hydrochloride Tabletsmsn.com - July 13 at 8:27 AMThe Latest Analyst Ratings for Corvus Pharmamarkets.businessinsider.com - June 16 at 7:38 PMTianjin Zhongxin Pharmaceutical Group Corp. Ltd.wsj.com - June 14 at 2:19 PMEx-‘Pharma Bro’ Martin Shkreli Now Living in Queens on $2,500 a Monthmsn.com - May 24 at 1:42 AMIronwood Pharmaceuticals to Buy VectivBio for About $1 Billionbarrons.com - May 22 at 1:30 PMCosmos Pharmaceutical Corp (3349)investing.com - May 18 at 6:45 PMOptimind Pharma Corp (OMND)investing.com - May 14 at 9:33 AMStella Pharma Corp (4888)uk.investing.com - May 11 at 9:45 AMAngelini Pharma and JCR Pharmaceuticals Announce Global Collaboration for the Development and Commercialization of Novel Biologic Therapies in Epilepsybusinesswire.com - May 11 at 9:45 AMHPGC Renmintongtai Pharmaceutical Corp (600829)investing.com - May 10 at 1:33 PMCorbus Pharmaceuticals Q1 FY23 R&D Expenses Grow 307% To $13.4Mmsn.com - May 9 at 5:31 PMKeyBanc Reaffirms Their Buy Rating on Recursion Pharmaceuticals (RXRX)markets.businessinsider.com - May 9 at 5:31 PMClosing Bell: Nervgen Pharma Corp down on Monday (NGEN)theglobeandmail.com - May 4 at 12:15 AMClosing Bell: Big Pharma Split Corp up on Monday (PRM)theglobeandmail.com - May 4 at 12:15 AMEagle Pharmaceuticals Granted Unique J-Code for Byfavo®¹ (remimazolam for injection) from CMStechnews.tmcnet.com - May 1 at 7:30 AMJW Pharmaceutical Corp. Pfd. Series 1wsj.com - April 22 at 10:50 PMBionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.finance.yahoo.com - April 20 at 2:19 PMBravo Pharma partners with G42 Healthcare to spearhead the field of Genomicsmsn.com - April 5 at 10:31 AM'No Contamination' In Sample of Eye Drops Manufactured by Global Pharma Healthcare, Say Reportsmsn.com - April 4 at 8:08 AM Get Correvio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CORV and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. CORV Media Mentions By Week CORV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORV News Sentiment▼0.000.32▲Average Medical News Sentiment CORV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORV Articles This Week▼00▲CORV Articles Average Week Get Correvio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CORV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACST News FBRX News SLGL News SPRB News LEXX News APRE News QLI News DRRX News ITRM News EYEN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Correvio Pharma Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
